Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin A (IgA) deficiency susceptibility 1 | 0.861 | 0.077 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2003 | |||||||||
|
microRNA 6891 | 1.000 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
long intergenic non-protein coding RNA 1991 | 0.890 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.130 | None | 1.000 | 3 | 2 | 2010 | 2016 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
Fc receptor like 3 | 0.612 | 0.769 | 6.0E-21 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
TNF receptor superfamily member 13B | 0.558 | 0.769 | 2.1E-15 |
|
disease | 0.320 | limited | 1.000 | 3 | 0 | 2009 | 2017 | ||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2010 | ||||||||
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1992 | 1992 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
aspartylglucosaminidase | 0.570 | 0.808 | 4.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
recombination activating 1 | 0.509 | 0.769 | 2.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
neutrophil cytosolic factor 1 | 0.521 | 0.808 | 2.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
interleukin 22 | 0.393 | 0.885 | 1.9E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2010 | ||||||||
|
interleukin 5 | 0.437 | 0.846 | 5.7E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 1998 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |